RecruitingMelanoma
In Vivo Real-time Detection of Circulating Melanoma Cells
Eligible age
18–80 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The objective of this clinical trial is to determine whether a Photoacoustic flow cytometry (PAFC)-based prototype device can detect circulating tumor cells (CTCs) in the blood of melanoma patients in vivo, in real time, and do so at detection limits at least one order of magnitude below the detection limits of currently existing ex vivo methods.
Sponsor: University of Arkansas
You may qualify if…
- ✓ Age 18 to 80 years
- ✓ Histological documented diagnosis of melanoma
- ✓ Signed informed consent form approved by the University of Arkansas for Medical Sciences (UAMS) Institutional Review Board (IRB)
- ✓ Must be able to sit still for 90 minutes
You may not qualify if…
- ✕ Active infection
- ✕ Current and significant medical or surgical condition as determined by the Investigator
- ✕ Diagnosis or evidence of organic brain syndrome
- ✕ Pregnancy or breastfeeding
Where it's recruiting
Arkansas
Little Rock
Source: ClinicalTrials.gov · NCT01776905 · last updated 2026-06-17